The global ocular drug delivery technology market is witnessing steady growth, driven by the increasing prevalence of vision-related disorders and advancements in drug delivery systems. Valued at US$ 16.3 Bn in 2023, the market is projected to reach US$ 30.2 Bn by 2034, expanding at a CAGR of 5.7%. As eye diseases become more common across aging populations and digital lifestyles, the need for...